Gallagher Publishes OpEd in The Hill on the USMCA
GDP Center Director Kevin Gallagher outlines how the pharmaceutical industry will benefit from the U.S.-Mexico-Canada Agreement (USMCA).
Emergency BU Alert Important Announcement: Update from BU IS&T: Some Microsoft services continue to be unavailable including Outlook, Microsoft Teams and other online services. Please check TechWeb (http://bu.edu/tech) for further updates. A final update will be sent when Microsoft confirms services have been restored.
GDP Center Director Kevin Gallagher outlines how the pharmaceutical industry will benefit from the U.S.-Mexico-Canada Agreement (USMCA).